Literature DB >> 15337542

Status of postmastectomy radiotherapy in the United States: a patterns of care study.

Julia White1, Jennifer Moughan, Lori J Pierce, Monica Morrow, Jean Owen, J Frank Wilson.   

Abstract

PURPOSE: The Patterns of Care Study performed this first known practice survey to establish a national profile of the delivery of postmastectomy radiotherapy (RT) in operable breast cancer. METHODS AND MATERIALS: A Patterns of Care Study research associate collected data from 55 randomly selected institutions. The survey data included 132 items describing the patient, pathologic features, and treatment course for patients with clinical Stage I, II, and IIIA breast cancer undergoing postmastectomy RT in 1998 and 1999. A multivariate analysis was performed to determine the impact of tumor factors and type of treatment facility on the radiation fields used.
RESULTS: A weighted sample size of 13,720 was obtained from a sampling of 405 patient records. The mean tumor size was 3.5 cm, and the mean number of axillary nodal metastases was 4.55. Lymphatic vascular invasion was noted in 34%, microscopic skin or dermal lymphatic invasion in 16%, positive or close margins in 36%, and extracapsular nodal extension in 23%. Radiotherapy included the chest wall in all cases and the regional nodes in 78%. When nodal RT was delivered, it included a supraclavicular field, supplemental axillary field, and/or an internal mammary field in 98%, 46%, and 23% of cases, respectively. Chest wall and supraclavicular RT was delivered in >90% of instances with 6-MV photons to doses between 45 and 50 Gy. More variation was seen in the delivery of the axillary and internal mammary RT. On multivariate analysis, the presence of four or more positive nodes and treatment at a large-volume facility were the factors most frequently associated with the use of regional radiation fields.
CONCLUSION: This Patterns of Care Study survey has demonstrated that breast cancer patients undergoing postmastectomy RT in 1998 and 1999 had a high proportion of factors associated with an increased risk of locoregional failure. The practice patterns established in this study provide a baseline for comparison with future survey results.

Entities:  

Mesh:

Year:  2004        PMID: 15337542     DOI: 10.1016/j.ijrobp.2004.02.035

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  Postmastectomy radiotherapy in intermediate-risk patients: the gray zone.

Authors:  Carolyn I Sartor
Journal:  Curr Oncol Rep       Date:  2006-01       Impact factor: 5.075

2.  Acute Toxicity From Breast Cancer Radiation Using Helical Tomotherapy With a Simultaneous Integrated Boost.

Authors:  Andrzej P Wojcieszynski; Anna K Olson; Yi Rong; Randall J Kimple; Poonam Yadav
Journal:  Technol Cancer Res Treat       Date:  2015-03-16

3.  Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control.

Authors:  Yu-Jing Zhang; Julia L Oh; Gary J Whitman; Puneeth Iyengar; Tse-Kuan Yu; Welela Tereffe; Wendy A Woodward; George Perkins; Thomas A Buchholz; Eric A Strom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-12-11       Impact factor: 7.038

4.  Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer.

Authors:  Raweewan Liengsawangwong; Tse-Kuan Yu; Tzouh-Liang Sun; Jeremy J Erasmus; George H Perkins; Welela Tereffe; Julia L Oh; Wendy A Woodward; Eric A Strom; Mohammad Salephour; Thomas A Buchholz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-01       Impact factor: 7.038

5.  Breast-conserving surgery after neoadjuvant chemotherapy in patients with locally advanced cancer. Preliminary results.

Authors:  M Vergine; P Scipioni; S Garritano; M Colangelo; A Di Paolo; G Livadoti; A Maturo; M Monti
Journal:  G Chir       Date:  2013 Sep-Oct

6.  The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer.

Authors:  Vincent Vinh-Hung; Pauline T Truong; Wolfgang Janni; Nam Phong Nguyen; Georges Vlastos; Gábor Cserni; Melanie E Royce; Wendy A Woodward; Donald Promish; Patricia Tai; Guy Soete; Sabine Balmer-Majno; Bruno Cutuli; Guy Storme; Christine Bouchardy
Journal:  Strahlenther Onkol       Date:  2009-03-28       Impact factor: 3.621

7.  Regional lymph node radiotherapy in breast cancer: single anterior supraclavicular field vs. two anterior and posterior opposed supraclavicular fields.

Authors:  Mohammad Houshyari; Amir Shahram Yousefi Kashi; Sakineh Soleimani Varaki; Afshin Rakhsha; Eftekhar Rajab Blookat
Journal:  Electron Physician       Date:  2015-06-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.